ArticleThe Journal of infectious diseases2012

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.

Geraldine A O'Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.